1. Home
  2. MDXH vs MCHX Comparison

MDXH vs MCHX Comparison

Compare MDXH & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • MCHX
  • Stock Information
  • Founded
  • MDXH 2003
  • MCHX 2003
  • Country
  • MDXH Belgium
  • MCHX United States
  • Employees
  • MDXH N/A
  • MCHX N/A
  • Industry
  • MDXH
  • MCHX Business Services
  • Sector
  • MDXH
  • MCHX Consumer Discretionary
  • Exchange
  • MDXH Nasdaq
  • MCHX Nasdaq
  • Market Cap
  • MDXH 78.3M
  • MCHX 70.3M
  • IPO Year
  • MDXH 2021
  • MCHX 2004
  • Fundamental
  • Price
  • MDXH $2.53
  • MCHX $1.83
  • Analyst Decision
  • MDXH Strong Buy
  • MCHX
  • Analyst Count
  • MDXH 2
  • MCHX 0
  • Target Price
  • MDXH $7.50
  • MCHX N/A
  • AVG Volume (30 Days)
  • MDXH 44.6K
  • MCHX 18.9K
  • Earning Date
  • MDXH 11-06-2024
  • MCHX 11-06-2024
  • Dividend Yield
  • MDXH N/A
  • MCHX N/A
  • EPS Growth
  • MDXH N/A
  • MCHX N/A
  • EPS
  • MDXH N/A
  • MCHX N/A
  • Revenue
  • MDXH $80,741,000.00
  • MCHX $48,818,000.00
  • Revenue This Year
  • MDXH $24.45
  • MCHX N/A
  • Revenue Next Year
  • MDXH $15.22
  • MCHX $6.76
  • P/E Ratio
  • MDXH N/A
  • MCHX N/A
  • Revenue Growth
  • MDXH 45.51
  • MCHX N/A
  • 52 Week Low
  • MDXH $0.35
  • MCHX $1.11
  • 52 Week High
  • MDXH $4.64
  • MCHX $2.15
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 37.08
  • MCHX 51.07
  • Support Level
  • MDXH $2.84
  • MCHX $1.66
  • Resistance Level
  • MDXH $2.74
  • MCHX $1.80
  • Average True Range (ATR)
  • MDXH 0.12
  • MCHX 0.09
  • MACD
  • MDXH -0.05
  • MCHX -0.03
  • Stochastic Oscillator
  • MDXH 0.00
  • MCHX 52.63

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

Share on Social Networks: